FDA Lays Out Three Ways to Fight US Opioid Crisis in New Report
February 20, 2023
The US Food and Drug Administration (FDA) has outlined three steps in a newly released report that it can take to help combat the ongoing opioid crisis. The report, entitled the External Review of FDA Regulation of Opioid Analgesics Final Report, examines how the agency acted upon the 2017 findings of the National Academies for Sciences, Engineering, and Medicine (NASEM). The first is to evaluate study designs that consider public health for regulatory decision-making. In addition,
According to Emily Kimber, “It is also recommended that the agency considers seeking certain additional government authorities regarding opioid approvals and review of the advertising and promotion for such products. The third recommendation advises the FDA be ‘as transparent as possible’ regarding decision-making for opioids in order to encourage appropriate use, promote innovation in pain management and enhance public trust.”
To read more, click here.
(Source: PM Live, February 20th, 2023)
